Summary and Conclusions
A short clinical trial of Methoxyflurane, a new potent fluorinated ether, is reported. This agent is non-toxic, non-irritating, non-explosive and can be used with the ordinary vapourisers. Any degree of relaxation can be achieved with it. It can be used with carbon dioxide absorbers and does not seem to increase cardiac irritability. Recovery period is usually quiet. Its disadvantages are slow induction when used alone and hypotension if anaesthesia is too deep. We feel that further work is desirable to estimate its post-operative analgesic effects more fully and to assess the effect of adrenaline on the heart when used with this drug.
Similar content being viewed by others
References
Artusio, J. F. Jr.,et al. A Clinical Evaluation of Methoxyflurane in Man.Anaes-thesiology 21 : 512 Sept./Oct., '60.
North W. C.et al. Respiratory Circulatory & Hepatic Effects of Methoxyflurane in-Dogs.Anaesthesiology 22 : 138, Jan./Feb., '61.
Dobkin, A. B. Comparison of the Cardiovascular Respiratory and Metabolic Effects of Methoxyflurane and Halothane in Dogs.Anaesthesiol. 22 : 355, May June, '61.
Bamforth, F. J.,et al. Effect of Epinephrine on the Dog Heart during Methody flurane Anaesthesia.Anaesthesiol, 22 : 169, March April, '61.
Israel,et al. Acta Anaes. Scand. Vol. 6, No. 1.
Thompson.Anaesth. and Analg., March, 1962.
Power, D. J. McGill University, Experiences with Methoxyflurane.Can. Anaes. Soc. J., Vol. 8, No. 5.
Kok,et al. S. A. Medical Congress, Sept., 1961.
Author information
Authors and Affiliations
Additional information
Read at Section of Anaesthetics, Royal Academy of Medicine in Ireland, 3rd May, 1962.
Rights and permissions
About this article
Cite this article
Woodcock, J.A., De Brit, B.P. & Keane, D. A clinical trial of methoxyflurane. I.J.M.S. 38, 167–170 (1963). https://doi.org/10.1007/BF02947196
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02947196